Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the S 1023 Medical Freedom topic
No spam. Unsubscribe anytime.
Senate State Affairs sends Idaho Medical Freedom Act to 14th Order for possible amendment after contested hearing
Summary
After hours of testimony, the Senate State Affairs Committee voted to send S 1023 — the Idaho Medical Freedom Act — to the 14th Order of Business for possible amendment. Supporters framed it as bodily-autonomy protection; opponents warned its broad definitions could undermine public-health rules and businesses' emergency actions.
The Senate State Affairs Committee advanced S 1023, the Idaho Medical Freedom Act, to the 14th Order of Business for possible amendment following a lengthy hearing that split public-health, industry and liberty advocates.
Senator Foreman presented the bill as an expansion of the Coronavirus Stop Act that would bar businesses and government entities from requiring most “medical interventions,” while carving out an exception for entities that receive Centers for Medicare and Medicaid Services (CMS) funds. Leslie Manookian, president of the Health Freedom Defense Fund, testified that the measure would prevent coercive medical interventions and keep employers from conditioning jobs on medical procedures.
Opponents—including business and public-health witnesses—called the bill’s language too broad. Alex LeBeau of the Idaho Association of Commerce and Industry said the original negotiated statutes already protected employers and warned S 1023 could unsettle existing workplace and safety practices. Representatives of public-health and school nursing raised concerns that the bill would conflict with Idaho Code Title 39, Chapter 40 and could limit authorities who respond to outbreaks.
Industry witnesses also flagged operational risks. Elizabeth Criner of Food Northwest said the language could prevent manufacturers from setting requirements intended to protect the food supply; Pam Eaton, president and CEO of the Idaho Retailers Association, asked whether the bill would prohibit businesses from administering life-saving treatments such as EpiPens or Narcan in emergencies. Chairman Guthrie raised a related question about whether defibrillators could be maintained on business premises under the draft language.
Supporters framed S 1023 as protecting individual liberty. Several witnesses recounted personal medical concerns and skepticism about interventions; Fred Birnbaum of the Idaho Freedom Foundation urged limiting the power of government in medical decisions and noted recent federal court rulings affecting private-sector vaccine mandates.
After sponsor remarks and additional discussion, Senator Anthon moved to send S 1023 to the 14th Order of Business for possible amendment; the motion carried by voice vote. Chairman Guthrie and Senator Ruchti asked to be recorded as voting nay. The committee did not adopt text changes at the hearing; staff and sponsors indicated amendment work would occur if the bill reaches the 14th Order.
The committee’s action does not adopt or defeat the bill on its merits; forwarding the measure to the 14th Order signals the sponsor may seek modifications before floor consideration.
